No abstract available
MeSH terms
-
Adenocarcinoma / classification*
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / immunology
-
Aged
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Female
-
Humans
-
Neoplasms / classification*
-
Neoplasms / drug therapy*
-
Neoplasms / immunology
-
Nivolumab / therapeutic use*
-
Prognosis
-
Remission Induction
Substances
-
Antineoplastic Agents, Immunological
-
Nivolumab